AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
drug development
Better Drug Commercialization Strategies Powered by AI
The drug commercialization process is one of the most important and challenging steps in drug development. Creating a successful strategy rests on guidance provided by reliable data from multiple sources. In an increasingly competitive landscape, pharma companies need powerful solutions that make the commercialization process more efficient and increase the likelihood of success. Today, meeting …
Better Drug Commercialization Strategies Powered by AI Read More »
Revolutionizing Drug Discovery with AI-Powered Solutions
Drug discovery plays a key role in the pharma and biotech industries. Discovering unmet needs, pinpointing the target, identifying the lead, and optimizing the drug development process present significant challenges. Initially, the drug discovery process was more serendipitous rather than a planned process. Today, drug discovery involves a streamlined progression from identification to optimization. It …
Revolutionizing Drug Discovery with AI-Powered Solutions Read More »
Leveraging the Role of AI for More Successful Clinical Trials
The pharmaceutical industry spends billions on R&D each year. Clinical trials require tremendous amounts of effort, from identifying sites and enrolling patients to overseeing research functions and coordinating trial logistics. Trials often run over budget or are delayed because of a number of factors, such as an inadequate number of patients available for the study, …
Leveraging the Role of AI for More Successful Clinical Trials Read More »
Leveraging AI for Drug Discovery in early stage Biotech Companies
Many biotech firms lack the basic data infrastructure to properly exploit digital tools and AI-technologies like machine learning, computer vision, entity normalization, network analysis, etc, and they don’t employ their own data scientists. However, some investors are specifically looking at biotech companies combining the DNA of both pharmaceutical and digital technology groups. Funding is only …
Leveraging AI for Drug Discovery in early stage Biotech Companies Read More »
